PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för xyloketal B. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

19 hits

Bibliografisk träff 2023-02-24

Chemoenzymatic Synthesis of (+)-Xyloketal B.

Romero EO, Perkins JC, Burch JE, Delgadillo DA, Nelson HM, Narayan ARH.

Org Lett · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1021/acs.orglett.3c00334

Bibliografisk träff 2022-06-24

Xyloketal B Reverses Nutritional Hepatic Steatosis, Steatohepatitis, and Liver Fibrosis through Activation of the PPARα/PGC1α Signaling Pathway.

Tong Y, Zhu W, Wen T, Mukhamejanova Z, Xu F, Xiang Q, Pang J.

J Nat Prod · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jnatprod.2c00259

Bibliografisk träff 2021-08-08

Xyloketal B: A marine compound with medicinal potential.

Gong H, Bandura J, Wang GL, Feng ZP, Sun HS.

Pharmacol Ther · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.pharmthera.2021.107963

Bibliografisk träff 2018-12-27

Xyloketal derivative C53N protects against mild traumatic brain injury in mice.

Liang F, Su F, Wang X, Long S, Zheng Y, He X, Pang J, Pei Z.

Drug Des Devel Ther · research-article; journal article · DOI 10.2147/dddt.s177951

Bibliografisk träff 2018-12-19

Marine Compound Xyloketal B as a Potential Drug Development Target for Neuroprotection.

Gong H, Luo Z, Chen W, Feng ZP, Wang GL, Sun HS.

Mar Drugs · review-article; review; journal article · DOI 10.3390/md16120516

Bibliografisk träff 2018-03-29

Xyloketal B exerts antihypertensive effect in renovascular hypertensive rats via the NO-sGC-cGMP pathway and calcium signaling.

Zhao LY, Li J, Huang XQ, Wang GH, Lv XF, Meng WF, Chen WL, Pang JY, Lin YC, Sun HS, Wang GL, Du YM.

Acta Pharmacol Sin · research-article; journal article · DOI 10.1038/aps.2018.12

Bibliografisk träff 2017-06-03

Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models.

Zhang Y, Meng T, Zuo L, Bei Y, Zhang Q, Su Z, Huang Y, Pang J, Xiang Q, Yang H.

Mar Drugs · research-article; journal article · DOI 10.3390/md15060163

Bibliografisk träff 2017-05-29

Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway.

Pan N, Lu LY, Li M, Wang GH, Sun FY, Sun HS, Wen XJ, Cheng JD, Chen JW, Pang JY, Liu J, Guan YY, Zhao LY, Chen WL, Wang GL.

Acta Pharmacol Sin · research-article; journal article · DOI 10.1038/aps.2017.22

Bibliografisk träff 2015-04-22

Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways.

Chen WL, Turlova E, Sun CL, Kim JS, Huang S, Zhong X, Guan YY, Wang GL, Rutka JT, Feng ZP, Sun HS.

Mar Drugs · research support, non-u.s. gov't; research-article; journal article · DOI 10.3390/md13042505

Bibliografisk träff 2015-04-14

Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.

Zhao LY, Li J, Yuan F, Li M, Zhang Q, Huang YY, Pang JY, Zhang B, Sun FY, Sun HS, Li Q, Cao L, Xie Y, Lin YC, Liu J, Tan HM, Wang GL.

Mar Drugs · research support, non-u.s. gov't; research-article; journal article · DOI 10.3390/md13042306

Bibliografisk träff 2014-12-24

Marine compound xyloketal B reduces neonatal hypoxic-ischemic brain injury.

Xiao AJ, Chen W, Xu B, Liu R, Turlova E, Barszczyk A, Sun CL, Liu L, Deurloo M, Wang GL, Feng ZP, Sun HS.

Mar Drugs · research support, non-u.s. gov't; research-article; journal article · DOI 10.3390/md13010029

Bibliografisk träff 2014-12-12

Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study.

Su J, Chang C, Xiang Q, Zhou ZW, Luo R, Yang L, He ZX, Yang H, Li J, Bei Y, Xu J, Zhang M, Zhang Q, Su Z, Huang Y, Pang J, Zhou SF.

Drug Des Devel Ther · research support, non-u.s. gov't; research-article; journal article · DOI 10.2147/dddt.s73476

Bibliografisk träff 2013-02-18

Xyloketal B exhibits its antioxidant activity through induction of HO-1 in vascular endothelial cells and zebrafish.

Li ZX, Chen JW, Yuan F, Huang YY, Zhao LY, Li J, Su HX, Liu J, Pang JY, Lin YC, Lu XL, Pei Z, Wang GL, Guan YY.

Mar Drugs · research support, non-u.s. gov't; research-article; journal article · DOI 10.3390/md11020504

Bibliografisk träff 2011-12-13

A validated high-performance liquid chromatographic method with diode-array detection for the estimation of xyloketal B in rat plasma.

Zhang W, Liu Y, Yang H, Li Z, Huang Y, Xu Z, Lin Y, Xiang Q, Pang J.

J Chromatogr B Analyt Technol Biomed Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jchromb.2011.12.005

Bibliografisk träff 2010-06-01

Design and synthesis of novel xyloketal derivatives and their vasorelaxing activities in rat thoracic aorta and angiogenic activities in zebrafish angiogenesis screen.

Xu Z, Li Y, Xiang Q, Pei Z, Liu X, Lu B, Chen L, Wang G, Pang J, Lin Y.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm1001502

Bibliografisk träff 2010-03-27

Protective effects of xyloketal B against MPP+-induced neurotoxicity in Caenorhabditis elegans and PC12 cells.

Lu XL, Yao XL, Liu Z, Zhang H, Li W, Li Z, Wang GL, Pang J, Lin Y, Xu Z, Chen L, Pei Z, Zeng J.

Brain Res · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1016/j.brainres.2010.03.071

Bibliografisk träff 2009-09-16

Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage.

Zhao J, Li L, Ling C, Li J, Pang JY, Lin YC, Liu J, Huang R, Wang GL, Pei Z, Zeng J.

Brain Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.brainres.2009.09.034

Bibliografisk träff 2009-05-27

A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro.

Chen WL, Qian Y, Meng WF, Pang JY, Lin YC, Guan YY, Chen SP, Liu J, Pei Z, Wang GL.

Biochem Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bcp.2009.05.029

Bibliografisk träff 2006-02-01

Synthesis of xyloketal A, B, C, D, and G analogues.

Pettigrew JD, Wilson PD.

J Org Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jo052371+